| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4764336
Max Phase: Preclinical
Molecular Formula: C33H31N7O2
Molecular Weight: 557.66
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCOc1nc2cccc(C(=O)NCCc3ccc(C)cc3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
Standard InChI: InChI=1S/C33H31N7O2/c1-3-42-33-35-29-10-6-9-28(32(41)34-20-19-23-13-11-22(2)12-14-23)30(29)40(33)21-24-15-17-25(18-16-24)26-7-4-5-8-27(26)31-36-38-39-37-31/h4-18H,3,19-21H2,1-2H3,(H,34,41)(H,36,37,38,39)
Standard InChI Key: NCMKYPSJGYUVQM-UHFFFAOYSA-N
Associated Targets(Human)
NEDD8-activating enzyme E1 regulatory subunit 121 Activities
A549 127892 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 557.66 | Molecular Weight (Monoisotopic): 557.2539 | AlogP: 5.61 | #Rotatable Bonds: 10 |
| Polar Surface Area: 110.61 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 4.23 | CX Basic pKa: 1.91 | CX LogP: 6.62 | CX LogD: 5.02 |
| Aromatic Rings: 6 | Heavy Atoms: 42 | QED Weighted: 0.23 | Np Likeness Score: -1.24 |
References
| 1. Chen X,Yang X,Mao F,Wei J,Xu Y,Li B,Zhu J,Ni S,Jia L,Li J. (2021) Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo., 210 [PMID:33129593] [10.1016/j.ejmech.2020.112964] |
Source
Source(1):